Serum MIF, GP73, PIVKA-II, AFP-L3 and AFP all have certain diagnostic value for primary liver cancer, and the combination of five serological tumor markers for detection can significantly improve the sensitivity, specificity and accuracy of the diagnosis of primary liver cancer, with a higher diagnostic value. This evidence concerns the gene GOLM1 and liver cancer.